Bristol Myers Squibb (BMY) Receivables (2009 - 2026)
Bristol Myers Squibb (BMY) reported Receivables of $10.66 billion for Q2 2026, down 18.7% from $13.12 billion a year earlier and down 1.2% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Receivables (2009 - 2026) Analysis & Trends
At the end of FY2025, Bristol Myers Squibb posted Receivables of $13.24 billion, up 6.0% from FY2024.
- Receivables has a five-year compound annual growth rate of 6.2% (FY2020 to FY2025).
- By year, Receivables came in at $12.48 billion in FY2024 (-3.7%), $12.96 billion in FY2023 (+11.5%), $11.62 billion in FY2022 (+8.0%) and $10.76 billion in FY2021 (+10.0%).
- The Q2 2026 figure ranks as the lowest quarterly Receivables since Q4 2022.
- Year over year, Receivables gained in five of the last eight quarters, with an average decline of 2.3%.
- The high point for year-over-year Receivables in five years was Q1 2023 (growth of 24.2%); the low point was Q2 2026 (a decline of 18.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $10.79 billion (Q1 2026), $11.61 billion (Q4 2025) and $13.22 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Bristol Myers Squibb | 126.07 Bn | 77.35 Bn | 9.25 Bn | 10.66 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.66 Bn |
| Mar 31, 2026 | 10.79 Bn |
| Dec 31, 2025 | 11.61 Bn |
| Sep 30, 2025 | 13.22 Bn |
| Jun 30, 2025 | 13.12 Bn |
| Mar 31, 2025 | 12.54 Bn |
| Dec 31, 2024 | 11.13 Bn |
| Sep 30, 2024 | 12.74 Bn |
| Jun 30, 2024 | 13.10 Bn |
| Mar 31, 2024 | 12.07 Bn |
| Dec 31, 2023 | 11.34 Bn |
| Sep 30, 2023 | 12.20 Bn |
| Jun 30, 2023 | 12.10 Bn |
| Mar 31, 2023 | 12.25 Bn |
| Dec 31, 2022 | 10.39 Bn |
| Sep 30, 2022 | 11.21 Bn |
| Jun 30, 2022 | 10.52 Bn |
| Mar 31, 2022 | 9.87 Bn |
| Dec 31, 2021 | 9.73 Bn |
| Sep 30, 2021 | 10.61 Bn |
API Access
Bristol Myers Squibb Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();